创新药物的成本上升:前景和建议
Antonio Vallano1,2,3, Caridad Pontes3,4
1Drug Harmonization Program, Medicines Area, Catalan Health Service, Barcelona, Spain.
Frontiers in public health
|October 9, 2024
概括
药品成本的上升挑战了公共卫生保健,威胁到基本服务和公平的获取. 为了金融稳定和人口福祉,需要创新的定价和健康驱动的支付模式.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 公共卫生 公共卫生
背景情况:
- 药品成本不断上升使公共卫生预算受到压力,从基本服务中转移资金,影响患者获取医疗服务.
- 目前基于价值的定价模式与向疗法和精准医学扎,造成了财务可持续性的挑战.
研究的目的:
- 探索战略,以确保公共卫生保健系统的长期可访问性,效率和财务稳定性,以应对不断上升的药物成本.
- 建议对针对小患者群体的新疗法进行评估方法和管理访问策略的调整.
主要方法:
- 分析与药品支出相关的当前医疗保健融资挑战.
- 审查现有的定价和报销框架.
- 探索潜在的解决方案,包括监管改革,国际合作和修订的支付模式.
主要成果:
- 传统的定价框架和向治疗的发展之间存在不匹配,导致成本上升.
- 提出的解决方案包括公平的定价,透明的投资,监管改革,以及转向以健康为导向的支付模式.
- 针对不确定性和小人群的评估方法的调整对于新疗法至关重要.
结论:
- 转向以健康为导向的支付模式,专注于结果而不是成本,对于可持续的医疗保健至关重要.
- 需要一种协作,适应和透明的方法来平衡制药创新与财务可持续性.
- 重构定价和获取系统是必要的,以使治疗成本与实际的健康结果和人口福祉保持一致.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Prescription, Nonprescription and Orphan Drugs
701
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
701
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacovigilance
783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241


